Financial Architects, Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$33.21 - $51.27 $4,981 - $7,690	-150 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$26.12 - $43.27 $3,918 - $6,490	150 New	150 $6,000
Q1 2018 Apr 23, 2018	SELL	$3.72 - $7.64 $3,720 - $7,640	-1,000 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$1.69 - $4.33 $1,690 - $4,330	1,000	1,000 $4,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.